ask="20.80"
ask_size="100"
average_daily_volume="198123"
bid="17.65"
bid_size="2100"
book_value="7.04"
change="+0.80"
change_from_200_day_moving_average="3.43"
change_from_50_day_moving_average="-0.40"
change_from_52_week_high="-4.30"
change_From_52_week_low="7.65"
change_in_percent="+4.17%"
close="20.00"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-3.06"
ebitda="-79.91M"
eps_estimate_current_year="-3.17"
eps_estimate_next_quarter="-0.92"
eps_estimate_next_year="-3.33"
ex_dividend_date="N/A"
float_shares="18669000"
high="20.30"
high_52_weeks="24.30"
last_trade_date="1/31/2017"
last_trade_price="20.00"
last_trade_size="10983"
last_trade_time="4:00pm"
low="18.70"
low_52_weeks="12.35"
market_capitalization="570.30M"
moving_average_200_day="16.57"
moving_average_50_day="20.40"
name="Revance Therapeutics
Inc."
notes="N/A"
one_year_target_price="36.60"
open="19.25"
pe_ratio="N/A"
peg_ratio="-0.54"
percent_change_from_200_day_moving_average="+20.70%"
percent_change_from_50_day_moving_average="-1.96%"
percent_change_from_52_week_high="-17.70%"
percent_change_from_52_week_low="+61.94%"
previous_close="19.20"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.73"
price_per_sales="1824.96"
revenue="300000.00"
shares_outstanding="28515000"
short_ratio="22.14"
stock_exchange="NGM"
symbol="RVNC"
volume="124599"
weeks_range_52="12.35 - 24.30"
